Low -vs- High-Frequency Repetitive TMS of the Right Dorsolateral Prefrontal Cortex in PTSD
NCT ID: NCT02369614
Last Updated: 2019-03-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
30 participants
INTERVENTIONAL
2014-08-31
2019-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pathophysiological Understanding and Treatment of PTSD: an rTMS Approach
NCT03840369
Non Invasive Brain Stimulation for PTSD
NCT02442843
Repetitive Transcranial Magnetic Stimulation Plus Reactivation Therapy Efficacy on PTSD Symptom Severity in Resistant PTSD
NCT06111976
Theta-Burst Neuromodulation for PTSD
NCT02769312
TMS for PTSD and Blood Pressure
NCT05512143
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Subjects who qualify will be assigned by block randomization to one of four arms:
1. 1 Hz rTMS of the right dorsolateral prefrontal cortex
2. 10 Hz rTMS of the right dorsolateral prefrontal cortex
3. Sham rTMS of the right dorsolateral prefrontal cortex
4. OASIS treatment as usual
Treatment will be administered in 10 daily sessions, conducted on weekdays, for 2 consecutive weeks. .
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active Comparator:1 Hz rTMS
Active Comparator: 1 Hz rTMS
Active Comparator: 1 Hz rTMS
1 Hz rTMS
Active Comparator:10 Hz rTMS
Active Comparator:10 Hz rTMS
Active Comparator: 10 Hz rTMS
10 Hz rTMS
Sham Comparator:Sham rTMS
Sham Comparator: Sham rTMS
Sham Comparator:
Sham rTMS
OASIS treatment as usual
OASIS treatment as usual
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Active Comparator: 1 Hz rTMS
1 Hz rTMS
Active Comparator: 10 Hz rTMS
10 Hz rTMS
Sham Comparator:
Sham rTMS
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Willing and able to give informed consent
Diagnosis of Post-Traumatic Stress Disorder as determined by the CAPS CAPS score of at least 50
Males or females between 18-65 years of age
Exclusion Criteria
Patients with severe or unstable medical conditions, which in the opinion of the investigator would interfere with their progress or safety
ECT treatment within the last 30 days Patients with neurological disorder leading to increased intracranial pressure
Participation in other interventional treatment protocols (participants of monitoring/observational studies can be included)
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
United States Naval Medical Center, San Diego
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Donald Hurst
LCDR Donald Hurst, MD, MC USN
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Donald Hurst, MD
Role: PRINCIPAL_INVESTIGATOR
NMCSD
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NMCSD.2014.0061
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.